[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@yorvel5](/creator/twitter/yorvel5) "Citizens reiterated $MDGL Mkt OP/$470 after its 2Q25 survey showed a XX% prescription rate for Rezdiffra (up from XX% in its 1Q survey)" $IVA $AKRO $ALGS $VKTX ETNB SGMT LLY #MASH Citizens in its note to investors said "Our 2Q25 survey shows a XX% prescription rate for Rezdiffra (up from XX% in our 1Q survey) with XX% of patients on paid drug and consistent high persistence; we reiterate our Market Outperform rating and $XXX risk-adjusted DCF-derived price target on Madrigal Pharmaceuticals. Most metrics in our 2Q25 physician survey improved from 1Q which is a good sign coming out of the"  [@yorvel5](/creator/x/yorvel5) on [X](/post/tweet/1949508058675093999) 2025-07-27 16:31:55 UTC X followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@yorvel5
"Citizens reiterated $MDGL Mkt OP/$470 after its 2Q25 survey showed a XX% prescription rate for Rezdiffra (up from XX% in its 1Q survey)" $IVA $AKRO $ALGS $VKTX ETNB SGMT LLY #MASH Citizens in its note to investors said "Our 2Q25 survey shows a XX% prescription rate for Rezdiffra (up from XX% in our 1Q survey) with XX% of patients on paid drug and consistent high persistence; we reiterate our Market Outperform rating and $XXX risk-adjusted DCF-derived price target on Madrigal Pharmaceuticals. Most metrics in our 2Q25 physician survey improved from 1Q which is a good sign coming out of the"
@yorvel5 on X 2025-07-27 16:31:55 UTC X followers, XXX engagements